S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander episode artwork

EPISODE · Oct 31, 2024 · 27 MIN

S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander

from Treating Together · host Targeted Oncology

In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses the clinical importance of ESR1 mutations in hormone receptor-positive metastatic breast cancer and how these mutations influence treatment approaches.

Episode metadata supplied by the publisher feed · Published Oct 31, 2024

Embed this episode

Ready to play

S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander

0:00 27:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Treating Together?

This episode is 27 minutes long.

When was this Treating Together episode published?

This episode was published on October 31, 2024.

Can I download this Treating Together episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!